Abstract
Clinical and experimental evidence indicates a modulatory role of estrogens on the activity of nigrostriatal dopaminergic neurons (Hruska, 1985; Van Hartesveld & Joyce, 1986). However, conflicting data make the precise effects of estrogens on nigrostriatal dopaminergic system unclear, suggesting either a facilitatory (Nausieda et al., 1979; Hruska & Silbergeld., 1980; Chiodo et al., 1981) or an inhibitory (Bedard et al., 1978; Chiodo et al., 1979; Euvrard et al., 1979; Gordon, 1980) role.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agid, Y., Javoy-Agid, F., 1985, Peptides and Parkinson’s disease, TINS, 8: 30–36.
Bedard, P., Langelier, P., Villeneuve, A., 1977, Oestrogens and extrapiramidal system. Lancet, II: 1367–1368.
Bedard, P., Dankova, J., Boucher, R., Langelier, P., 1978, Effect of estrogens on apomorphine-induced circling behaviour in the rat. Can. J. Physiol. Pharmacol., 65: 538–541.
Bedard, P., Langelier, P., Dankova, J., Villeneuve, A., Di Paolo, T., Barden, N., Labrie, F., Boissier, J.R., Euvrard, C., 1979, Estrogens, progesterone, and the extrapyramidal system, Adv. Neurol., 24: 411–422.
Brown, E., Brown, G.H., Kofman, O., Quarrington, B., 1978, Sexual function and affect in parkinsonian men treated with 1-Dopa. Am. J. Psychiatry, 135: 1552–1555.
Chiodo, L.A., Caggiula, A.R., Salter, C.F., 1979, Estrog3en increases both spiperone-induced catalepsy and brain levels of H spiperone in the rat. Brain Res., 172: 360–366.
Chiodo, L.A., Caggiula, A.R., Salter, C.F., 1981, Estrogen potentiates the stereotypy induced by dopamine agonists in the rat, Life Sci, 28: 827–835.
Conte-Devolx, B., Giraud, B., Castanas, E., Boudouresque, F., Orlando, M., Gillioz, P., Oliver, C., 1981, Effect of neonatal treatment with monosodium glutamate on the secretion of alpha-MSH, beta-endorphin and ACTH in the rat, Neuroendocrinology, 33: 207–211.
Den Hartog, W.A., Bethlem, J., 1960, The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralisis agitans, J. Neurol. Neurosurg. Psychiatry, 23: 283–90.
Eikenburg, D.C., Ravitz, A.J., Gudelsky, G.A., Moore, K.E., 1977, Effects of estrogen on prolactin and tuberoinfundibular dopaminergic neurons, J. Neural. Transm., 40: 235–244.
Euvrard, C., Labrie, F., Boissier, J.R., 1979, Effect of estrogen on changes in the activity of striatal cholinergic neurons induced by DA drugs, Brain Res., 169: 215–220.
Fahn, S., Elton, R.L., Agid, Y., Barbeau, A., Calne, D.B., Duvoisin, R.C., Hoehn, M.M., Jankovic, J., Klawans, H.L., Lang, A.E., Lataste, X., Liebermann, A.N., Marsden, C.D., Markham, C.H., Mayeux, R., Rinne, U.K., Stern, G.M., Teychenne, P., Yahr, M.D., 1987, Unified Parkinson’s disease rating scale, in: “Recent development in Parkinson’s disease (Vol. II)”, S. Fahn, C.D. Marsden, D.B. Caine, M. Goldstein, eds., Mcmillan Healthcare information, New York.
Fioretti, P., Cagnacci, A., Paoletti, A.M., Gambacciani, M., Soldani, R., Mauro, G.A., Spinetti, A., Melis, G.B., 1989, Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women, J. Endocrinol. Invest., 12: 295–301.
Folstein, M.F., Folstein, S.E., McHugh, P.R., 1975, Mini Mental State, a practical method for grading the cognitive state of patients for the clinician, J. Psychiatry Res., 12: 189–193.
Giovannini, P., Martinez-Campos, A., Scigliano, G., Caraceni, T., 1981, Morbo di Parkinson ed estrogeni, in: “Atti della 7” Riunione della Lega Italiana per la Lotta contro it Morbo di Parkinson e le Malattie Extrapiramidali“, A. Agnoli, G. Bertolani, eds., D. Guanella, Roma.
Gordon, J.H., 1980,. Modulation of apomorphine-induced stereotipy by estrogen: time course and dose response, Brain Res. Bull., 5: 679–682.
Gross, K.M., Matsumoto, A.M., Bremner, W.J., 1987, Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man, J. Clin. Endocrinol. Metab., 64: 675–680.
Hall,J.E., Brodie, T.D., Badger, T.M., Rivier, J., Vale, W., Conn, P.M., Shoenfeld, D., Crowley, W.F., 1988, Evidence of differential control of FSH and LH secretion by gonadotropìn-releasing hormone ( GnRH) from the use of a GnRH antagonist, J. Clin. Endocrinol. Metab., 63: 524–531.
Hamilton, M., 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23: 56–62.
Hornykiewicz, 0., Kish, S.J., 1986, Biochemical pathophysiology of Parkinson’s disease, Adv. Neurol., 45: 19–34.
Hruska, R.E., Silbergeld, E.K., 1980, Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model, Science, 208: 1466–1467.
Hruska, R.E., 1985, Sex hormone exposure and nonreproductive behaviour, Int. J. Ment. Health., 14: 112–134.
Hyyppa, M.T. Langvik, V.A., Rinne U.K., 1978 Plasma pituitary hormones in patients with Parkinson’s disease treated with bromocriptine, J. Neural. Transm., 42: 151–157.
Javoy-Agid, F., Ruberg, M., Pique, L., Bertagna, X., Taquet, H., Studler, J.M., Cesselin, F., Epelbaum, J., Agid, Y., 1984, Biochemistry of hypothalamus in Parkinson’s disease, Neurology, 34: 672–675.
Koller, W.C., Barr, A., Biary, N., 1982, Estrogen treatment of dyskinetic disorders, Neurology, 32: 547–549.
Langston, J.W., Forno, L.S., 1978, The hypothalamus in Parkinson’s disease, Ann. Neurol., 3: 129–133.
Ling, N., Ying, S.Y., Ueno, N., Shimasaki, S., Esh, F., Hotta M., Guillemin, R., 1986, Pituitary FSH is released by a heterodimer of the 8-subunits from the two forms of inhibin, Nature, 321: 779–782.
Melis, G.B., Paoletti, A.M., Gambacciani, M., Mais, V., Fioretti, P., 1984,. Evidence that estrogens inhibit LH secretion trough opioids in postmenopausal women, Neuroendocrinology, 39: 60–63.
Melis, G.B., Gargiulo T., Pallotti, A., Gambacciani, M., Cagnacci, A., Paoletti, A.M., Petacchi, F.D., Fioretti, P., 1985, Disappearance of opioid control of LH secretion in short term ovariectomized women, J. Endocrinol. Invest., 8 (suppl. 2), 41–46.
Melis, G.B., Cagnacci, A., Gambacciani, M., Paoletti, A.M., Caffi, T., Fioretti, P., 1988, Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal women, Neuroendocrinology, 47: 159–163.
Nappi, G., Petraglia, F., Martignoni, E., Facchinetti, F., Bono, G., Genazzani, A.R., 1985, ß-endorphin cerebrospinal fluid decrease in untreated parkinsonian patients, Neurology, 35: 1371–1374.
Nausieda, P.A., Koller, W.C., Weiner, W.J., Klawans, H.L. 1979, Modification of postsynaptic dopaminergic sensitivity by female sex hormones, Life Sci., 25: 521–526.
Nutt, J.G., Woodward, W.R., Hammerstad, J.P., Carter, J.H., Anderson, J.L., 1984, The on-off phenomenon in Parkinson’s disease. Relation to levodopa absorption and transport, N. Eng. J. Med., 310: 483–488.
Quigley, M.E., Yen, S.S.C., 1980, The role of endogenous opiates on LH secretion during the menstrual cycle, J. Clin. Endocrinol, Metab., 51: 179–181.
Raymond, V., Beaulieu, M., Labrie, F., Boissier, J.R., 1978, Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release, Science, 200: 1173–1175.
Rasmussen, D.D., Liu, J.H., Wolf, P.K., Jen, S.S.C., 1986,. Gonadotropin-releasing hormone neurosecretion in the human hypothalamus. In vitro regulation by dopamine, J. Clin. Endocrinol., Metab., 62: 479–483.
Rasmussen, D.D., Liu, J.H., Wolf, P.L., Yen, S.S.C., 1987, Neurosecretion of human hypothalamic immunoreactive ß-endorphin: in vitro regulation by dopamine, Neuroendocrinology, 45: 197–200.
Reid, R.L., Quigley, M.E., Yen, S.S.C., 1983, The disappearance of opioidergic regulation of gonadotropin secretion in postmenomausal women, J. Clin. Endocrinol. Metab., 57: 1107–1110.
Rinne, U.K., 1979, Neuroendocrine and extrapyramidal dopamine neurons in Parkinson’s disease, in: “Neuroendocrine Correlates in Neurology and Psychiatry”, E.E. Muller, A. Agnoli, eds., Elsevier, Amsterdam, pp. 119–125.
Rivier, C., Rivier, J., Vale, W., 1986, Inhibin-mediated feedback control of follicle-stimulating hormone secretion in the female rat, Science, 234: 205–208.
Sandyk, R., 1989, Estrogens and the pathophysiology of Parkinson’s disease, Intern. J. Neurosci., 45: 119–122.
Shoupe, D., Montz, F.J., Lobo, R.A., 1985, The effects of estrogens and progestins on endogenous opioid activity in oophorectomized women, J. Clin. Endocrinol. Metab., 60: 178–183.
Vale, W., Rivier, J., Vaughan, J., McClintock, R., Corrigan, A., Woo, W., Karr, D., Spiess, J., 1986, Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid, Nature, 321, 776–779.
Van Hartesveldt, C., Joyce, J.N., 1986, Effects of estrogen on the basal ganglia, Neurosci. Biobehay. Rev., 10: 1–14.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Bonuccelli, U. et al. (1991). Clinical and Neuroendocrinological Effects of Estrogens in Postmenopausal Women with Parkinson’s Disease. In: Bernardi, G., Carpenter, M.B., Di Chiara, G., Morelli, M., Stanzione, P. (eds) The Basal Ganglia III. Advances in Behavioral Biology, vol 39. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5871-8_79
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5871-8_79
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5873-2
Online ISBN: 978-1-4684-5871-8
eBook Packages: Springer Book Archive